aztreonam has been researched along with Hematologic Diseases in 7 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Hematologic Diseases: Disorders of the blood and blood forming tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One hundred and nine patients with infection accompanying hematologic disorders including leukemia and lymphoma were treated with aztreonam (AZT)." | 3.67 | [Therapeutic effectiveness of aztreonam on severe infections associated with hematologic disorders. Hanshin Infection Study Group]. ( Hirayama, F; Horiuchi, A; Kawagoe, H; Kitani, T; Masaoka, T; Nagai, K; Okamoto, Y; Shibata, H; Yasunaga, K; Yonezawa, T, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakata, Y | 1 |
| Sawada, Y | 1 |
| Kuroe, K | 1 |
| Nakaji, S | 1 |
| Takami, H | 1 |
| Tsushima, K | 1 |
| Saito, S | 1 |
| Ogasawara, H | 1 |
| Shinagawa, H | 1 |
| Soma, N | 1 |
| Urabe, A | 1 |
| Takaku, F | 1 |
| Mizoguchi, H | 1 |
| Nomura, T | 1 |
| Aoki, N | 1 |
| Yamaguchi, H | 1 |
| Mutoh, Y | 1 |
| Miura, Y | 1 |
| Toyama, K | 1 |
| Hirashima, K | 1 |
| Hirotsu, T | 1 |
| Akatsuka, J | 1 |
| Hoshi, Y | 1 |
| Uchiyama, H | 1 |
| Fujisawa, K | 1 |
| Kobayashi, N | 1 |
| Ishidoya, N | 1 |
| Ohira, M | 1 |
| Takayama, J | 1 |
| Ishida, Y | 1 |
| Takemoto, Y | 1 |
| Kanamaru, A | 1 |
| Nagai, K | 2 |
| Masaoka, T | 2 |
| Kitani, T | 2 |
| Horiuchi, A | 2 |
| Yonezawa, T | 2 |
| Yasunaga, K | 2 |
| Kageyama, T | 1 |
| Tatsumi, N | 1 |
| Shimazaki, C | 1 |
| Inaba, T | 1 |
| Murakami, S | 1 |
| Oku, N | 1 |
| Itoh, K | 1 |
| Ura, Y | 1 |
| Nakagawa, M | 1 |
| Fujita, N | 1 |
| Sakata, H | 1 |
| Kakehashi, H | 1 |
| Fujita, K | 1 |
| Yoshioka, H | 1 |
| Hirayama, F | 1 |
| Shibata, H | 1 |
| Kawagoe, H | 1 |
| Okamoto, Y | 1 |
3 trials available for aztreonam and Hematologic Diseases
| Article | Year |
|---|---|
[A randomized controlled study on imipenem/cilastatin sodium in comparison to aztreonam + lincomycin in treating severe infections in patients with malignant tumors or hematological diseases].
Topics: Adolescent; Adult; Aged; Aztreonam; Cilastatin; Drug Therapy, Combination; Female; Hematologic Disea | 1992 |
[Clinical evaluation of aztreonam for infections accompanying febrile neutropenic children with hematologic disorders and solid tumors. A cooperative study].
Topics: Adolescent; Age Factors; Aztreonam; Bacterial Infections; Cefmetazole; Child; Child, Preschool; Drug | 1990 |
Randomized trial of combination antibiotic therapy in patients with hematological disorders. Hanshin Study Group of Hematopoietic Disorders and Infection.
Topics: Adolescent; Adult; Aged; Amikacin; Aztreonam; Clindamycin; Drug Administration Schedule; Drug Therap | 1990 |
4 other studies available for aztreonam and Hematologic Diseases
| Article | Year |
|---|---|
[Combination therapy with aztreonam and clindamycin on severe infections accompanying neutropenic patients with hematological disorders].
Topics: Adult; Aged; Aztreonam; Bacterial Infections; Clindamycin; Drug Evaluation; Drug Therapy, Combinatio | 1990 |
[Effect of combination therapy with carumonam and clindamycin on severe infections in patients with hematologic malignancies].
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Clindamycin; Drug Evaluation; D | 1990 |
[Selective decontamination of intestinal flora with oral aztreonam in compromised children].
Topics: Administration, Oral; Adolescent; Aztreonam; Child; Child, Preschool; Colony Count, Microbial; Decon | 1989 |
[Therapeutic effectiveness of aztreonam on severe infections associated with hematologic disorders. Hanshin Infection Study Group].
Topics: Adolescent; Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbia | 1985 |